SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : ADVR:THE NEW COMPANY...WITH A NEW LIFE...AND A NEW MISSION
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Kingfisher who wrote (4634)11/16/1999 11:19:00 PM
From: Kingfisher  Read Replies (2) of 4891
 
MORE:

We have three patents for the use of Reticulose(TM) as a treatment. In addition, we have filed 34 patent applications with the United States Patent
Office, INCLUDING ONE FOR RETICULOSE(TM) AS A PRODUCT. We cannot be certain that other companies, having greater economic resources, will not be successful in developing a similar product using processes similar to ours. We cannot be certain that we will obtain such a patent or, if obtained, that it will be enforceable. We have retained patent counsel for the purpose of pursuing additional patent protection for Reticulose(TM). However, we are uncertain that any patents will be granted, or if granted, that such patents will be sustained if questioned, and, if declared valid, that the patents, in fact, will operate to protect us from the replication of Reticulose(TM) by competitors. We have relied upon laws protecting proprietary information and trade secrets and upon confidentiality agreements to protect our rights to Reticulose(TM) and the processes for its manufacture, but we are uncertain as to whether such efforts and procedures will continue to be successful and protect us from any competition in the future.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News